162 related articles for article (PubMed ID: 31452763)
1. Cyclin-dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma.
Deng Y; Han Q; Mei S; Li H; Yang F; Wang J; Ge S; Jing X; Xu H; Zhang T
Oncol Lett; 2019 Sep; 18(3):2845-2852. PubMed ID: 31452763
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer.
Yu MH; Luo Y; Qin SL; Wang ZS; Mu YF; Zhong M
Am J Cancer Res; 2015; 5(9):2708-18. PubMed ID: 26609478
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
[TBL] [Abstract][Full Text] [Related]
7. DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.
Banas T; Pitynski K; Okon K; Czerw A
Onco Targets Ther; 2017; 10():4579-4589. PubMed ID: 29075126
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
Kita Y; Nishizono Y; Okumura H; Uchikado Y; Sasaki K; Matsumoto M; Setoyama T; Tanoue K; Omoto I; Mori S; Owaki T; Ishigami S; Nakagawa H; Tanaka F; Mimori K; Mori M; Natsugoe S
Oncol Rep; 2014 May; 31(5):1986-92. PubMed ID: 24604089
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma.
Yasutake N; Iwasaki T; Yamamoto H; Sonoda K; Kodama K; Okugawa K; Asanoma K; Yahata H; Kato K; Oda Y
Pathol Res Pract; 2022 Jul; 235():153920. PubMed ID: 35605413
[TBL] [Abstract][Full Text] [Related]
10. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
[TBL] [Abstract][Full Text] [Related]
11. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373
[TBL] [Abstract][Full Text] [Related]
13. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma.
Travaglino A; Raffone A; Raimondo D; Gencarelli A; Esposito I; Gallo C; Improda FP; Vitale SG; Mollo A; Casadio P; Seracchioli R; Zullo F; Insabato L
Arch Gynecol Obstet; 2023 Feb; 307(2):379-386. PubMed ID: 35344084
[TBL] [Abstract][Full Text] [Related]
16. DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma.
Ke Y; You L; Xu Y; Wu D; Lin Q; Wu Z
Front Oncol; 2022; 12():1084192. PubMed ID: 36531033
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
[TBL] [Abstract][Full Text] [Related]
18. The Functional Role and Regulatory Mechanism of FTO m
Yang Q; Al-Hendy A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175660
[TBL] [Abstract][Full Text] [Related]
19. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas.
Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi D; Sabbatini P; Soslow RA
Int J Gynecol Cancer; 2006; 16(2):849-53. PubMed ID: 16681772
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer.
Yu M; Zhong M; Qiao Z
Oncol Lett; 2013 Sep; 6(3):777-780. PubMed ID: 24137409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]